Facebook
Twitter
LinkedIn
ForwardMayo Clinic COVID-19 Live Webinar Series May 19, 2020 Online CME Course
On May 19 at 9 a.m. CT, Mayo Clinic held a live webinar covering ongoing COVID-19 research at Mayo Clinic, including convalescent plasma trials, vaccine development, virology, and infection prevention.
Panel Moderator Gregory J. Gores, M.D., Executive Dean for Research, Mayo Clinic, led a discussion with the following experts:
Andrew D. Badley, M.D., Chair, Mayo Clinic COVID-19 Task Force
Michael J. Joyner, M.D., Principal Investigator, Expanded Access Program (EAP) for convalescent plasma to fight COVID-19
Elie F. Berbari, M.D., Chair, Division of Infectious Diseases
The views and perspectives shared in these resources are presented based on information available at the time of recording.
Learning Objectives
Upon completion of the Mayo Clinic COVID-19 Live Webinar Series course, learners should be able to:
- Discuss current research initiatives related to the COVID-19 pandemic
- Identify promising innovative solutions for treatment strategies in COVID-19 patients
- Describe the expedited translational research related to COVID-19
- Describe innovative practice redesign principles to treat patients in a virtual setting.
Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course.
Additional Information
| Attachment | Size |
|---|---|
 Additional Information | 121.74 KB |
Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
Relevant financial relationship(s) with industry:
None
No relevant financial relationship(s) with industry:
Barbara L. Baasch Thomas
Andrew D. Badley, M.D.
Elie F. Berbari, M.D.
Jen Curran
Gregory J. Gores, M.D.
Mitchell R. Humphreys, M.D.
Michael J. Joyner, M.D.
Reference to off-label usage(s) of pharmaceuticals or instruments in their presentation:
Andrew D. Badley, M.D.
Hydroxychloroquine, HIV protease inhibitors, MMPD, Remdesivir, Plasma, Lenzilumab, Tocilizumab Sarilumab, Ecilizumab, Ravulizumab, Losartan
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statements:
AMA
Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
A record of attendance will be provided to all registrants for requesting credits in accordance with state nursing boards, specialty societies or other professional associations.
For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
Price
If you attended and claimed CME credit for the Live Webinar on May 19, you are unable to access the Online CME course. To view the recording, please click here.
Notify me for future live webinars
Access to online streaming course is available from the date of purchase until the course expires on May 19, 2023. Credit must be claimed within that time period.
Cancellation and Refund Policy
View Cancellation and Refund Policy
All requests must be submitted in writing using the Contact Us Form.
Any use of this site constitutes your agreement to the Terms and Conditions of Registration.